Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

A systematic review of the performance characteristics of clinical event monitor signals used to detect adverse drug events in the hospital setting.

Handler SM, Altman RL, Perera S, Hanlon JT, Studenski SA, Bost JE, Saul MI, Fridsma DB.

J Am Med Inform Assoc. 2007 Jul-Aug;14(4):451-8. Epub 2007 Apr 25. Review. Erratum in: J Am Med Inform Assoc. 2007 Sep-Oct;14(5):686.

2.

Assessing the performance characteristics of signals used by a clinical event monitor to detect adverse drug reactions in the nursing home.

Handler SM, Hanlon JT, Perera S, Saul MI, Fridsma DB, Visweswaran S, Studenski SA, Roumani YF, Castle NG, Nace DA, Becich MJ.

AMIA Annu Symp Proc. 2008 Nov 6:278-82.

3.

Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.

Carnevali L, Krug B, Amant F, Van Pee D, Gérard V, de Béthune X, Spinewine A.

Ann Pharmacother. 2013 Nov;47(11):1414-9. doi: 10.1177/1060028013500939.

PMID:
24285758
4.

Adverse drug event detection in pediatric oncology and hematology patients: using medication triggers to identify patient harm in a specialized pediatric patient population.

Call RJ, Burlison JD, Robertson JJ, Scott JR, Baker DK, Rossi MG, Howard SC, Hoffman JM.

J Pediatr. 2014 Sep;165(3):447-52.e4. doi: 10.1016/j.jpeds.2014.03.033. Epub 2014 Apr 25.

5.

Computerized surveillance of adverse drug events in hospital patients.

Classen DC, Pestotnik SL, Evans RS, Burke JP.

JAMA. 1991 Nov 27;266(20):2847-51. Erratum in: JAMA 1992 Apr 8;267(14):1922.

PMID:
1942452
6.

A computerized adverse drug event alerting system using clinical rules: a retrospective and prospective comparison with conventional medication surveillance in the Netherlands.

Rommers MK, Teepe-Twiss IM, Guchelaar HJ.

Drug Saf. 2011 Mar 1;34(3):233-42. doi: 10.2165/11536500-000000000-00000.

PMID:
21332247
7.

Can surveillance systems identify and avert adverse drug events? A prospective evaluation of a commercial application.

Jha AK, Laguette J, Seger A, Bates DW.

J Am Med Inform Assoc. 2008 Sep-Oct;15(5):647-53. doi: 10.1197/jamia.M2634. Epub 2008 Jun 25.

8.

Automated surveillance for adverse drug events at a community hospital and an academic medical center.

Kilbridge PM, Campbell UC, Cozart HB, Mojarrad MG.

J Am Med Inform Assoc. 2006 Jul-Aug;13(4):372-7. Epub 2006 Apr 18.

9.

Evaluation of a computer-based adverse-drug-event monitor.

Hwang SH, Lee S, Koo HK, Kim Y.

Am J Health Syst Pharm. 2008 Dec 1;65(23):2265-72. doi: 10.2146/ajhp080122.

PMID:
19020194
10.

Adverse drug events among adult inpatients: a meta-analysis of observational studies.

Martins AC, Giordani F, Rozenfeld S.

J Clin Pharm Ther. 2014 Dec;39(6):609-20. doi: 10.1111/jcpt.12204. Epub 2014 Sep 15. Review.

PMID:
25219403
11.

Evaluation of rule effectiveness and positive predictive value of clinical rules in a Dutch clinical decision support system in daily hospital pharmacy practice.

Rommers MK, Zwaveling J, Guchelaar HJ, Teepe-Twiss IM.

Artif Intell Med. 2013 Sep;59(1):15-21. doi: 10.1016/j.artmed.2013.04.001. Epub 2013 May 7.

PMID:
23664455
12.

Comparing the effectiveness of computerized adverse drug event monitoring systems to enhance clinical decision support for hospitalized patients.

Petratos GN, Kim Y, Evans RS, Williams SD, Gardner RM.

Appl Clin Inform. 2010 Sep 1;1(3):293-303. doi: 10.4338/ACI-2009-11-RA-0009. Print 2010.

13.

Methods for assessing the preventability of adverse drug events: a systematic review.

Hakkarainen KM, Andersson Sundell K, Petzold M, Hägg S.

Drug Saf. 2012 Feb 1;35(2):105-26. doi: 10.2165/11596570-000000000-00000. Review.

PMID:
22201475
14.

Development of a computerized adverse drug event monitor.

Evans RS, Pestotnik SL, Classen DC, Bass SB, Menlove RL, Gardner RM, Burke JP.

Proc Annu Symp Comput Appl Med Care. 1991:23-7.

15.

Predictive value of alert triggers for identification of developing adverse drug events.

Moore C, Li J, Hung CC, Downs J, Nebeker JR.

J Patient Saf. 2009 Dec;5(4):223-8. doi: 10.1097/PTS.0b013e3181bc05e5.

PMID:
22130215
16.

Preventing adverse drug events in hospitalized patients.

Evans RS, Pestotnik SL, Classen DC, Horn SD, Bass SB, Burke JP.

Ann Pharmacother. 1994 Apr;28(4):523-7.

PMID:
8038479
17.

Medication safety program reduces adverse drug events in a community hospital.

Cohen MM, Kimmel NL, Benage MK, Cox MJ, Sanders N, Spence D, Chen J.

Qual Saf Health Care. 2005 Jun;14(3):169-74.

18.

Strategies for detecting adverse drug events among older persons in the ambulatory setting.

Field TS, Gurwitz JH, Harrold LR, Rothschild JM, Debellis K, Seger AC, Fish LS, Garber L, Kelleher M, Bates DW.

J Am Med Inform Assoc. 2004 Nov-Dec;11(6):492-8. Epub 2004 Aug 6.

19.

Construct and concurrent validity of a patient-reported adverse drug event questionnaire: a cross-sectional study.

de Vries ST, Haaijer-Ruskamp FM, de Zeeuw D, Denig P.

Health Qual Life Outcomes. 2014 Aug 13;12:103. doi: 10.1186/s12955-014-0103-6.

20.

Supplemental Content

Support Center